Donated medicines for neglected tropical diseases have improved the lives of billions. Together, we can ensure those still at risk are #NeglectedNoMore.
A Historic Public-Private Partnership
In 2012, 10 companies joined governments, civil society, private funders, multilateral agencies and academia to endorse the London Declaration on Neglected Tropical Diseases – a collective commitment to reach the World Health Organization’s (WHO) goals to control, eliminate and eradicate 10 neglected tropical diseases (NTDs).
The London Declaration is one of the great public health success stories of recent history. Since 2012, 39 countries have eliminated at least one NTD, and more than 600 million people are no longer at significant risk of contracting an NTD. From 2016 to 2019, more than one billion people received treatment for at least one NTD each year - hundreds of millions more than before the London Declaration.
Donations of NTD medications, which are distributed by WHO, have been a longtime pillar of the fight against NTDs – many pharmaceutical company donation programs have existed for decades. Since the London Declaration, companies have donated more than 14 billion treatments to NTD programs as part of their commitment to reduce global poverty and create a fairer, healthier world.